ProShare Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,477
| Closed | -$24.2K | – | 2155 |
|
|
2024
Q4 | $24.2K | Buy |
+11,477
| New | +$24.2K | ﹤0.01% | 2248 |
|
|
2022
Q2 | – | Sell |
-11,590
| Closed | -$72K | – | 1937 |
|
|
2022
Q1 | $72K | Sell |
11,590
-2,737
| -19% | -$17K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $101K | Buy |
+14,327
| New | +$101K | ﹤0.01% | 2204 |
|
|
2021
Q2 | – | Sell |
-10,229
| Closed | -$56K | – | 2384 |
|
|
2021
Q1 | $56K | Buy |
+10,229
| New | +$56K | ﹤0.01% | 2220 |
|
|
2014
Q2 | – | Sell |
-25,816
| Closed | -$122K | – | 2517 |
|
|
2014
Q1 | $122K | Buy |
+25,816
| New | +$122K | ﹤0.01% | 2652 |
|
|
2013
Q4 | – | Sell |
-21,363
| Closed | -$85K | – | 1562 |
|
|
2013
Q3 | $85K | Buy |
21,363
+270
| +1% | +$1.07K | ﹤0.01% | 2453 |
|
|
2013
Q2 | $76K | Buy |
+21,093
| New | +$76K | ﹤0.01% | 2311 |
|